ArticleNature communications2025

Increased risk of antimicrobial resistance in patients with cirrhosis and hepatic encephalopathy using rifaximin.

Cheng-Hao Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.